HL GENOMICS Co., Ltd.

Research HL GENOMICS Co., Ltd. (0156T0.KQ) on Bullrun: market cap KRW 59.14B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker0156T0.KQ
ExchangeKQ
CountrySouth Korea
SectorHealthcare
IndustryPharmaceutical Retailers
CurrencyKRW
Market capKRW 59.14B
Financial periodQ2 2026
RevenueKRW 6.61B
Net incomeKRW 1.79B
Free cash flowKRW 2.36B
Gross margin44.8%

Valuation Snapshot

latest market cap is KRW 59.14B.

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	KRW 59.14B	n/a	n/a	n/a

Dividend history

About HL GENOMICS Co., Ltd.

HL GENOMICS Co., Ltd. manufactures medicinal chemicals and antibiotics. The company offers APIs (active pharmaceutical ingredients) and intermediates. The company was founded in 2000 and is based in Yongin-si, South Korea. HL GENOMICS Co., Ltd. operates as a subsidiary of Hanlim Pharm.Co.,Ltd.

Related stock research

South Korea stocks South Korea Healthcare stocks A-Z stock index

Other Healthcare stocks

BLUEMTEC Co., Ltd. (439580.KQ) Cellromax Science Co., Ltd. (471820.KQ) Dongwha Pharm.Co.,Ltd (000020.KS) Yuhan Corporation (000100.KS) Yuyu Pharma, Inc. (000220.KS) Ildong Holdings Co., Ltd. (000230.KS) Samil Pharmaceutical Co.,Ltd (000520.KS) Dong-A Socio Holdings Co., Ltd. (000640.KS) JW Pharmaceutical Corporation (001060.KS) JPI Healthcare Co.,Ltd. (0010V0.KQ) SAMSUNG PHARM. Co., LTD. (001360.KS) Ahn-Gook Pharmaceutical Co., Ltd. (001540.KQ)

Frequently asked questions

What is HL GENOMICS Co., Ltd.'s market cap?

HL GENOMICS Co., Ltd.'s market capitalization is KRW 59.14B.